Immunological biomarkers at birth and later risk of celiac disease
摘要
The role of immune cell profiles at birth in determining the risk of celiac disease (CD) development is currently unestablished. This study aimed to determine the associations between T- and B-cell profiles at birth and pediatric CD.
MethodsThis regional cohort study analyzed prospectively collected dried blood spots from 158 children with CD (median 7 years old at CD diagnosis) and two matched comparators each (n = 316). We quantified T-cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs) as measures of thymic and bone marrow output at birth. Moreover, we used epigenetic cell counting to estimate the percentages of lymphocyte subsets: CD3+, CD4+, CD8 + T cells, CD4 + memory T, regulatory T, B, and NK cells.
ResultsNo associations were found between measured immune cell markers at birth and CD development (all p values > 0.26). The median number of copies was 120 for TRECs (IQR = 92–168) and 136 (IQR = 91–183) for CD patients and comparators, respectively, and for KRECs, it was 69 (IQR = 45–100) for CD patients and 66 for comparators (IQR = 44–93). Across the groups, there were similar median percentages of T cells (CD, 32.6% [IQR = 27.0–43.8%] vs. comparators, 33.9% [IQR = 26.3–45.7%]) and B cells (CD, 25.4% [IQR = 20.3–30.6%] vs. comparators, 24.7% [IQR = 19.9–30.8%]). The ratio of the lymphocyte subset estimates between CD patients and comparators approximated one; all p values were > 0.26. The results were consistent across strata defined by sex, HLA type, and age at diagnosis.
ConclusionGenetic and epigenetic markers for B cells and T cells in immune cell profiles at birth did not impact susceptibility to childhood-onset CD.